Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q17142898> ?p ?o }
Showing triples 1 to 41 of
41
with 100 triples per page.
- Q17142898 subject Q15310543.
- Q17142898 subject Q7335370.
- Q17142898 subject Q8645495.
- Q17142898 subject Q8791920.
- Q17142898 subject Q8852392.
- Q17142898 abstract "TRV130 is an opioid drug that is under evaluation in human clinical trials for the treatment of acute severe pain.It is a functionally selective μ-opioid receptor agonist developed by Trevena Inc. TRV130 elicits robust G protein signaling, with potency and efficacy similar to morphine, but with far less β-arrestin 2 recruitment and receptor internalization, it displays less adverse effects than morphine.".
- Q17142898 atcPrefix "none".
- Q17142898 iupacName "[(3-Methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine".
- Q17142898 thumbnail TRV130.svg?width=300.
- Q17142898 wikiPageExternalLink TRV130.php.
- Q17142898 wikiPageWikiLink Q1135604.
- Q17142898 wikiPageWikiLink Q1258877.
- Q17142898 wikiPageWikiLink Q14911924.
- Q17142898 wikiPageWikiLink Q15310543.
- Q17142898 wikiPageWikiLink Q17145461.
- Q17142898 wikiPageWikiLink Q17832094.
- Q17142898 wikiPageWikiLink Q2047938.
- Q17142898 wikiPageWikiLink Q2066956.
- Q17142898 wikiPageWikiLink Q30612.
- Q17142898 wikiPageWikiLink Q389934.
- Q17142898 wikiPageWikiLink Q407438.
- Q17142898 wikiPageWikiLink Q427523.
- Q17142898 wikiPageWikiLink Q640448.
- Q17142898 wikiPageWikiLink Q7335370.
- Q17142898 wikiPageWikiLink Q7838954.
- Q17142898 wikiPageWikiLink Q81225.
- Q17142898 wikiPageWikiLink Q81938.
- Q17142898 wikiPageWikiLink Q828130.
- Q17142898 wikiPageWikiLink Q8645495.
- Q17142898 wikiPageWikiLink Q8791920.
- Q17142898 wikiPageWikiLink Q8852392.
- Q17142898 atcPrefix "none".
- Q17142898 iupacName "[methyl]amine".
- Q17142898 type ChemicalSubstance.
- Q17142898 type Drug.
- Q17142898 type ChemicalObject.
- Q17142898 type Thing.
- Q17142898 type Q8386.
- Q17142898 comment "TRV130 is an opioid drug that is under evaluation in human clinical trials for the treatment of acute severe pain.It is a functionally selective μ-opioid receptor agonist developed by Trevena Inc. TRV130 elicits robust G protein signaling, with potency and efficacy similar to morphine, but with far less β-arrestin 2 recruitment and receptor internalization, it displays less adverse effects than morphine.".
- Q17142898 label "TRV130".
- Q17142898 depiction TRV130.svg.